Investors Sue Eye Drug Co. After Manufacturing Issues
A potential class of Ocular Therapeutix Inc. investors sued the company in New Jersey federal court Friday, alleging it lied about the quality of its clinical trial-level eye disease drug Dextenza,...To view the full article, register now.
Already a subscriber? Click here to view full article